Hansa Biopharma AB's total assets for Q1 2025 were kr705.25M, a decrease of -11.91% from the previous quarter. DE:24H total liabilities were kr1.33B for the fiscal quarter, a -4.39% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.